| NEWSLETTER |
Click here to stay in touch
with our latest news. |
|
| NEWS | |
|
11/03/2010
- Cellvizio brings hope in Alabama
Shyam Varadarajulu, from UAB explains in the Birmingham Medical News how Cellvizio improves diagnostics, patient care and helps reduce procedures cost and time.
|
|
Cellvizio® Mouse Atlas with VisEn Medical Fluorescent Probes
Understanding biological processes: the power of molecular imaging by combined use of state-of-the-art technologies. (All images acquired on living animals!)
|
|
Vasculature of the kidney of a mouse after IV injection of AngioSense®680.
Images acquired with the Cellvizio®635. ProFlex: MiniO. Fov: 240 x 200 µm.
Courtesy of Raphaël Boisgard and Bertrand Tavitian, CEA-SHFJ, U803, Orsay, France.
|
|
Vasculature of the bladder of a mouse after IV injection of AngioSense®680.
Images acquired with the Cellvizio®635. ProFlex: prototype Z-Proflex. Fov: 400x280 µm.
Courtesy of Raphaël Boisgard and Bertrand Tavitian, CEA-SHFJ, U803, Orsay, France.
|
|
Vasculature of the intestine of a mouse after IV injection of AngioSense®680.
Images acquired with the Cellvizio®635. ProFlex: S-1500. Fov: 400x280 µm.
Courtesy of Raphaël Boisgard and Bertrand Tavitian, CEA-SHFJ, U803, Orsay, France.
|
|
Vascularization of a sub-cutanous tumor after IV injection of AngioSense®680.
Images acquired with the Cellvizio®635. ProFlex: MiniO. Fov: 240 µm.
Courtesy of Raphaël Boisgard and Bertrand Tavitian, CEA-SHFJ, U803, Orsay, France.
|
|
Vasculature of the liver of a mouse after IV injection of AngioSense®680.
Images acquired with the Cellvizio®635. ProFlex: MiniO. Fov: 240 µm.
Courtesy of Raphaël Boisgard and Bertrand Tavitian, CEA-SHFJ, U803, Orsay, France.
|
|
Vasculature of a tumor xenograft model after IV injection of AngioSense®680.
Images acquired with the Cellvizio®660. ProFlex: S-1500. Fov: 400 x 280 µm.
Courtesy of VisEn Medical
|
|
Visualization of colon vasculature with AngioSPARK™680.
Images acquire with the Cellvizio®660. ProFlex: S-1500. Fov: 400 x 280 µm.
Courtesy of Marco Maricevich, Center for Molecular Imaging Research, Massachusetts General Hospital, Boston, USA.
|
|
Vascularization of mouse cecum wall after IV injection of AngioSense®680.
Images acquired with the Cellvizio®660 and reconstructed with a mosaicing software plug-in. ProFlex: S-1500. Fov: 1.3 mm.
Courtesy of Marco Maricevich, Center for Molecular Imaging Research, Massachusetts General Hospital, Boston, USA.
|
|
Normal pancreas (upper dark image) and orthotopically implanted pancreatic cancer cells (lower image) imaged with ProSense®680. This couple of images illustrates the very good specificity of the combined use of the smart probe ProSense™ and the Cellvizio® for detection of tumoral activity.
Images acquired with the Cellvizio® 660. ProFlex: MiniO. Fov: 160 x 120 µm.
Courtesy of Dieter Saur, Johannes von Burstin, II. Medizinische Klinik, Technical University of Munich, Munich, Germany.
|
|
Mouse subcutanous tumor after IV injection of ProSense®680
Image acquired with the Cellvizio®660.
ProFlex: MiniO. Fov: 240 µm.
Courtesy of Frédéric Ducongé and Bertrand Tavitian, CEA-SHFJ, U803, Orsay, France
|
|
Mouse spleen after IV injection of ProSense®680
Image acquired with the Cellvizio®660.
ProFlex: MiniO. Fov: 240 µm.
Courtesy of Frédéric Ducongé and Bertrand Tavitian, CEA-SHFJ, U803, Orsay, France
|
|
|
CALENDAR |
|
|
02/05/2010
- DDW 2010
Come discover the latest Cellvizio developments at DDW 2010 in New Orleans. Visit us at booth #547 for a hands-on experience of Cellvizio.
|
|
